Company intelligence / Profile preview

CNCure Biotech

Hwasun-gun, Jeollanam-do, South Koreacncure.co.kr ↗
Ownership
Private
Development stage
Phase 1
01

Overview

CNCure is advancing a pipeline of bacteria-based cancer immunotherapies and radiopharmaceutical diagnostics. Its lead diagnostic agent [18F]DMPY2 for malignant melanoma has completed preclinical studies and is entering Phase 1/2a clinical trials. The flagship therapeutic candidate, SAM™ (Salmonella-based Armed Microbe), is in non-human primate toxicology studies. The company leverages proprietary AI technology for rapid drug discovery and molecular imaging to enable precision medicine approaches in oncology.

Therapeutic areas
Oncology
Modalities
Bacteria-based cancer immunotherapy (BCIT)RadiopharmaceuticalsAI-driven drug discovery platformsMolecular imaging agentsMicrobial-based therapies
Industry
Biotech
02

Drug pipeline

11 assets

SAM-01

Preclinical

10 more assets in the full pipeline.

03

Partnerships

Chonnam National University Medical School & College of AI Convergence (MOU signed)Korea Drug Development Fund projects

Beyond the preview

Go deeper on CNCure Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CNCure Biotech.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call